SUBSCRIBERS
Biolidics' Covid-19 rapid test kit allowed to be sold in EU
Published Mon, Apr 6, 2020 · 09:50 PM
Singapore
SINGAPORE-BASED cancer diagnos-tics company Biolidics on Monday said its rapid test kit for Covid-19 is allowed for sale in the European Union (EU).
This was after the test kit obtained confirmation for CE marking, a notification process to the relevant authority which allows the company to market and sell the kit in the EU. Having the CE marking confirms the test kit complies with the relevant EU product safety directives.
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
Companies & Markets
iPhone maker Hon Hai’s April sales rise 19% in positive signal
Worsening weather is igniting a US$25 billion market
TikTok tells advertisers: ‘We are not backing down’
EV automakers get reprieve in US tax credit rules
Nomura, Mizuho face losses on All Blue fund’s failed trades
Stablecoin Tether steps up monitoring in bid to combat illicit finance